ALFA Filings
Every announcement, straight from the exchange
Every iSERA Lifesciences annual general meeting announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements
iSERA Lifesciences Limited conducted its 34th Annual General Meeting on 29th September 2026, where shareholders adopted the audited financial statements and re-appointed a director.
iSERA Lifesciences has scheduled its 34th Annual General Meeting for September 29, 2026, and appointed a scrutinizer to oversee the voting process for the event.
iSERA Lifesciences issued a corrigendum to its Postal Ballot notice. It clarifies preferential equity share allotments and post-issue capital percentages.
iSERA Lifesciences Limited released its postal ballot scrutinizer report. Shareholders approved resolutions including share capital increases and related party transactions with requisite majority support.
iSERA Lifesciences Limited issued a postal ballot notice seeking approval for several matters, including a ₹78 Crore acquisition of iSERA Biological Limited via share swap. Other items include increasing authorised share capital to ₹25 Crore and adopting new articles and memorandum of association. Remote e-voting runs from April 22 to May 21, 2026.
Covidh Technologies Limited successfully concluded its EGM, where shareholders approved a company name change to 'iSERA Lifesciences Limited'. Additionally, four director appointments, including two Executive Directors and two Non-Executive Directors, were passed with a 100% majority of votes polled. The meeting recorded a voter turnout of 18.25% of the total outstanding shares.